(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Dec 31, 2022 | (Q6)Dec 31, 2022 | (Q3)Dec 31, 2022 | (FY)Dec 31, 2021 | (Q9)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Investment income receivable | 1.63%2.68B | 10.78%2.92B | -3.83%2.53B | 10.55%2.91B | -0.23%2.64B | -0.23%2.64B | 7.55%2.64B | -0.23%2.64B | 4.68%2.64B | 4.68%2.64B |
Insurance receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -10.39%1.29B | -10.39%1.29B |
Special items of assets | 5.03%872.9B | 0.23%832.96B | 2.13%848.78B | 3.39%859.21B | -9.05%831.05B | -9.05%831.05B | -5.04%831.05B | -9.05%831.05B | 4.26%913.71B | 4.26%913.71B |
Total assets | 5.02%875.57B | 0.26%835.87B | 2.11%851.31B | 3.41%862.12B | -9.15%833.69B | -9.15%833.69B | -5.17%833.69B | -9.15%833.69B | 4.24%917.64B | 4.24%917.64B |
Liabilities | ||||||||||
Insurance contract | 3.70%368B | ---- | ---- | ---- | -9.54%354.85B | ---- | ---- | ---- | 1.74%392.28B | 1.74%392.28B |
Investment contract | 17.23%11.82B | 15.54%11.65B | 4.74%10.56B | 4.62%10.55B | 223.36%10.08B | 223.36%10.08B | 219.56%10.08B | 223.36%10.08B | -5.20%3.12B | -5.20%3.12B |
Derivative financial liabilities | -17.91%11.73B | 20.75%17.25B | -14.38%12.23B | -16.87%11.88B | 42.35%14.29B | 42.35%14.29B | 22.48%14.29B | 42.35%14.29B | -32.91%10.04B | -32.91%10.04B |
Special items of liabilities | 7.15%435.31B | -0.41%757.94B | 2.66%781.36B | 3.92%790.95B | -10.39%406.25B | 67.88%761.1B | 74.47%761.1B | 67.88%761.1B | 7.04%453.34B | 7.04%453.34B |
Total liabilities | 5.27%826.85B | 0.18%786.84B | 2.38%804.16B | 3.55%813.37B | -8.54%785.46B | -8.54%785.46B | -4.77%785.46B | -8.54%785.46B | 3.80%858.77B | 3.80%858.77B |
Total assets less total liabilities | 1.04%48.73B | 1.68%49.04B | -2.22%47.16B | 1.09%48.75B | -18.08%48.23B | -18.08%48.23B | -11.11%48.23B | -18.08%48.23B | 11.06%58.87B | 11.06%58.87B |
Equity | ||||||||||
Share capital | -2.94%21.53B | -2.42%21.64B | -1.63%21.82B | -0.75%22.01B | -3.96%22.18B | -3.96%22.18B | -3.92%22.18B | -3.96%22.18B | 0.22%23.09B | 0.22%23.09B |
Other equity instruments | 433.77%257M | 315.58%166M | 77.92%-17M | -75.32%-135M | 93.76%-77M | 93.76%-77M | 90.86%-77M | 93.76%-77M | -57.27%-1.23B | -57.27%-1.23B |
Hold profit | 22.09%4.82B | 3.80%4.1B | 2.03%4.03B | 1.57%4.01B | -83.20%3.95B | -83.20%3.95B | -81.31%3.95B | -83.20%3.95B | 24.38%23.49B | 24.38%23.49B |
Special items of shareholders' equity | -0.28%20.69B | 4.42%21.67B | -4.27%19.86B | 2.91%21.35B | 75.51%20.75B | 75.51%20.75B | 123.85%20.75B | 75.51%20.75B | 13.62%11.82B | 13.62%11.82B |
Shareholders' equity | 0.35%47.04B | 1.13%47.41B | -2.49%45.71B | 1.06%47.38B | -19.74%46.88B | -19.74%46.88B | -12.33%46.88B | -19.74%46.88B | 11.60%58.41B | 11.60%58.41B |
Minority interests | 0.28%1.43B | 2.45%1.46B | 2.73%1.47B | 5.89%1.51B | -15.76%1.43B | -15.76%1.43B | -12.45%1.43B | -15.76%1.43B | 16.43%1.69B | 16.43%1.69B |
Total equity | 1.04%48.73B | 1.68%49.04B | -2.22%47.16B | 1.09%48.75B | -18.08%48.23B | -18.08%48.23B | -11.11%48.23B | -18.08%48.23B | 11.06%58.87B | 11.06%58.87B |
Total equity and total liabilities | 5.02%875.57B | 0.26%835.87B | 2.11%851.31B | 3.41%862.12B | -9.15%833.69B | -9.15%833.69B | -5.17%833.69B | -9.15%833.69B | 4.24%917.64B | 4.24%917.64B |
Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data